Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia.
South Australian Health and Medical Research Institute, Adelaide 5000, Australia.
Nutrients. 2023 Jun 9;15(12):2703. doi: 10.3390/nu15122703.
(1) Background: Observational studies associate vitamin D deficiency with muscle disorders, while some clinical trial data support a minor association between the vitamin and skeletal muscle performance in healthy subjects. Vitamin D receptor knockout mice studies confirm the relationship between vitamin D and skeletal muscle; however, causal inference in humans is challenging due to the ethical implications of including vitamin D-deficient participants in randomized trials. This study uses genetic methods to safely explore causal underpinnings for the relationship between 25(OH)D concentrations and skeletal muscle-related traits, including grip strength and combined arm skeletal muscle mass, and extends this analysis to suspected pathophysiology in the form of probable sarcopenia and sarcopenic obesity. (2) Methods: We conducted Mendelian randomization (MR) analyses in up to 307,281 participants from the UK Biobank of whom 25,414 had probable sarcopenia and 16,520 had sarcopenic obesity. In total, 35 variants were used to instrument 25(OH)D and MR analyses conducted using multiple approaches. (3) Results: Genetic analyses provided support for a relationship between genetically predicted higher 25(OH)D and skeletal muscle traits, with linear MR analyses for grip strength showing 0.11 kg (95% CI 0.04, 0.19) greater contractile force per 10 unit higher 25(OH)D, while there was a modest association with skeletal muscle mass (0.01 kg (95% CI 0.003, 0.02) greater muscle mass). For probable sarcopenia risk, there was suggestive evidence for lower odds by higher 25(OH)D (OR 0.96 (95% CI 0.92, 1.00)); however, this did not reflect an association with sarcopenic obesity (OR 0.97 (95% CI 0.93, 1.02)), but was seen in probable sarcopenia cases who were not obese (OR 0.92 (95% CI 0.86, 0.98)). Results were similar across multiple MR approaches. (4) Conclusions: Our study supports a causal relationship between 25(OH)D and skeletal muscle health. While evidence for benefit did not extend to lower risk of sarcopenic obesity, effective vitamin D-deficiency prevention strategies may help reduce age-related muscle weakness.
(1)背景:观察性研究将维生素 D 缺乏与肌肉疾病联系起来,而一些临床试验数据支持维生素与健康受试者骨骼肌肉性能之间存在轻微关联。维生素 D 受体敲除小鼠研究证实了维生素与骨骼肌肉之间的关系;然而,由于将维生素 D 缺乏的参与者纳入随机试验存在伦理问题,因此在人类中进行因果推断具有挑战性。本研究使用遗传方法安全地探索 25(OH)D 浓度与骨骼肌肉相关特征(包括握力和手臂骨骼肌肉总质量)之间关系的因果关系基础,并将这种分析扩展到可能的少肌症和少肌症肥胖的形式的疑似病理生理学。(2)方法:我们在英国生物银行的多达 307281 名参与者中进行了孟德尔随机化(MR)分析,其中 25414 名参与者患有疑似少肌症,16520 名参与者患有少肌症肥胖症。总共使用了 35 种变体来检测 25(OH)D,使用多种方法进行了 MR 分析。(3)结果:遗传分析支持较高的遗传预测 25(OH)D 与骨骼肌肉特征之间存在关系,线性 MR 分析显示,每增加 10 个单位的 25(OH)D,握力增加 0.11 公斤(95%CI 0.04,0.19),而与肌肉质量有适度的关联(0.01 公斤(95%CI 0.003,0.02)肌肉质量增加)。对于疑似少肌症风险,较高的 25(OH)D 与较低的患病几率呈正相关(OR 0.96(95%CI 0.92,1.00));然而,这与少肌症肥胖症无关(OR 0.97(95%CI 0.93,1.02)),但在不肥胖的疑似少肌症病例中观察到(OR 0.92(95%CI 0.86,0.98))。结果在多种 MR 方法中相似。(4)结论:我们的研究支持 25(OH)D 与骨骼肌肉健康之间存在因果关系。虽然没有证据表明预防少肌症肥胖症的风险降低,但有效的维生素 D 缺乏预防策略可能有助于减少与年龄相关的肌肉无力。